Company Filing History:

6 out of 389

Sanofi-aventis

Years Active: 1995-2013

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8557819 - Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics (2013-10-15),

2. 8541440 - Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics (2013-09-24),

3. 8524706 - 1,4-diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof (2013-09-03),

4. 8076340 - Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics (2011-12-13),

5. 7863290 - Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics (2011-01-04),

6. 7589201 - Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics (2009-09-15),

7. 7585974 - Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application (2009-09-08),

8. 7476674 - Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics (2009-01-13),

9. 7456171 - 1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof (2008-11-25),

10. 6143761 - 2,3-dihydrofuro [3,2-.beta.]pyridin, preparation and application thereof (2000-11-07),

11. 5929089 - 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one derivatives for (1999-07-27),

12. 5476942 - 1-[2-amino-5-[1-(triphenylmethyl)-1H-imidazol-4-YL]-1-oxopentyl] (1995-12-19),

13. 5453430 - 1-[2-(arylsulphonylamino)-1-oxoethyl]piperidine derivatives, their (1995-09-26),

Title: The Innovative Contributions of Frederic Galli

Introduction

Frederic Galli is a notable inventor based in Vaucresson, France. He has made significant contributions to the field of therapeutics, holding a total of 13 patents. His work focuses on the development of novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are two related to derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane. The first patent details the preparation method of these compounds and their use in therapeutics. The invention relates to compounds having a general formula (I), wherein R is defined within the patent. Additionally, it covers acid addition salts, hydrates, or solvates of these compounds. The second patent similarly addresses derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, emphasizing their preparation methods and therapeutic uses.

Career Highlights

Frederic Galli has had a distinguished career, working with prominent companies in the pharmaceutical industry. He has been associated with Sanofi-Aventis and Synthelabo, where he contributed to various innovative projects. His expertise in the field has allowed him to develop groundbreaking therapeutic compounds.

Collaborations

Frederic has collaborated with notable professionals in his field, including Alistair Lochead and Odile LeClerc. These collaborations have further enhanced his research and development efforts.

Conclusion

Frederic Galli's contributions to the field of therapeutics through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.